Summit Therapeutics (SMMT) EBIT Margin (QoQ) (2017 - 2022)
Powered by 
Analysis
Summit Therapeutics (SMMT) EBIT Margin (QoQ) (2017 - 2022) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Summit Therapeutics | 13.67 Bn | 12.98 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2022 | -229,915.00 |
| Jun 30, 2022 | 346,235.00 |
| Mar 31, 2022 | 151,409.00 |
| Dec 31, 2021 | -888,867.00 |
| Sep 30, 2021 | 4.01 Mn |
| Jun 30, 2021 | -3.28 Mn |
| Mar 31, 2021 | -256,758.00 |
| Dec 31, 2020 | 311,318.00 |
| Sep 30, 2020 | -32,673.00 |
| Jun 30, 2020 | -262,322.00 |
| Mar 31, 2020 | 1.24 Mn |
| Dec 31, 2019 | -1.46 Mn |
| Oct 31, 2019 | -239,529.00 |
| Oct 31, 2018 | -331,052.00 |
| Jul 31, 2018 | 55,128.00 |
| Apr 30, 2018 | 25,535.00 |
| Jan 31, 2018 | -23,026.00 |
| Oct 31, 2017 | -27,145.00 |
| Jul 31, 2017 | 48,148.00 |